Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial

Why did the Air India Boeing 787 crash happen? How will Trump's tariff threats impact the dollar? What caused Oracle's stock to hit a record high? Why was Sen. Alex Padilla forcibly removed at DHS press conference? How will JetZero's factory affect North Carolina jobs? Why is Google Cloud experiencing widespread outages? How is Trump's blocking of California's EV mandate affecting the market?

Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial

benzinga.com/news/health-care/25/06/45887132/novavaxs-experimental-covid-19-influenza-combo-shot-shows-immune-response-among-older-adults-in-

Novavax, Inc. (NASDAQ:NVAX) announced results Wednesday of the initial cohort of its COVID-19-Influenza Combination (CIC) and standalone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV) Phase 3 trial.
The study showed that the CIC and flu vaccine candidates induced immune…

This story appeared on benzinga.com, 2025-06-11 15:12:37.